Pain News and Research

Latest Pain News and Research

BIOLASE Technology honored with the Deloitte Tech Evolution Award

BIOLASE Technology, Inc. today announced that it is an inaugural winner of the Tech Evolution Award, an award that recognizes an elite group of companies that offer exceptional technologies that are transforming the technology industry. BIOLASE was announced as a recipient at a reception held on October 6 at The Island Hotel in Newport Beach, CA, by Deloitte & Touche LLP, host of the Tech Evolution Award and the Technology Fast 500.

8 Oct 2009

Muscle Flex develops a strong portfolio of 'Water' related products to maintain healthy lifestyle

Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it is developing a strong portfolio of "Water" related products to market using its direct response, online ecommerce and traditional retail methods. Muscle Flex® regards "Water" as potentially the most important ingredient in maintaining a healthy lifestyle and it is estimated that as much as 75% of Americans do not drink enough good clean water.

8 Oct 2009

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test.

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

New Palliative Medicine Fellowship program for Pacific Northwest physicians

While end-of-life care issues have come front and center in the current health care reform debate, physicians in the Pacific Northwest can now get more intensive training and new board certification in palliative medicine and hospice care.

8 Oct 2009

Biostar Pharmaceuticals' new drug application granted clearance for clinical trials

Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.

7 Oct 2009

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Clemson University researchers in collaboration with researchers at the University of Bremen, Germany, are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home setting.

7 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

Electrostimulation techniques for osteoarthritis still unclear

Despite twenty years of research on the use of electrostimulation techniques (TENS) for treatment of osteoarthritis in the knee, researchers still cannot say whether it reduces pain or physical disability. This is the conclusion of a Cochrane Systematic Review of electrostimulation trials in osteoarthritis

7 Oct 2009

Transenterix raises $55 million to manufacture and market its revolutionary laparoscopic surgical platform

TransEnterix Inc. has secured $55 million in a second round of institutional financing, paving the way for the company to manufacture and market its revolutionary laparoscopic surgical platform.

7 Oct 2009

Free educational brochure on physical therapy

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, today announced that a free educational brochure on the benefits of physical therapy is available to celebrate October as "National Physical Therapy Month," as designated by the American Physical Therapy Association.

7 Oct 2009

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

More studies that directly compare the effectiveness of different biologic drugs for rheumatoid arthritis (RA) are needed, say Cochrane Researchers. The researchers reviewed all previous Cochrane Systematic Reviews assessing the effectiveness of biologic disease-modifying drugs for treatment of RA and found that although all were very effective, there was little data on direct comparisons between the drugs that could help doctors decide which to prescribe.

7 Oct 2009

Opioid drugs may not be effective for osteoarthritis

Should you take opioid drugs for hip and knee pain caused by osteoarthritis? Probably not, suggests a new review of the best research on the subject.

7 Oct 2009

Cochrane Systematic Review finds Abatacept effective against rheumatoid arthritis

Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.

7 Oct 2009

New ultrasound probe effective for treating kidney stones

A relatively new ultrasound probe procedure has the highest success rate for breaking down kidney stones in the lower "funnel" area of the kidney, rather than the shock wave treatment used for many years, according to a review of studies.

7 Oct 2009

Research must focus on discovering potential causes and treatments for Bell's palsy

Drugs widely prescribed to treat facial paralysis in Bell's palsy are ineffective and are based on false notions of the cause of the condition, according to Cochrane Researchers. They say research must now focus on discovering other potential causes and treatments.

7 Oct 2009

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Data results published this month in Clinical Neuropharmacology, revealed that Merz Pharmaceuticals' NT 201 (botulinum toxin type A free from complexing proteins), also known by the brand name Xeomin in Europe and Canada, was statistically significantly more efficacious than placebo for the treatment of patients with post-stroke upper limb spasticity.

7 Oct 2009

Aerobic and strength training exercises safe and effective for rheumatoid arthritis patients

Exercise programs designed to improve strength and stamina are safe and effective treatments for rheumatoid arthritis (RA), according to a new Cochrane Systematic Review.

7 Oct 2009

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

Researchers from Boston University School of Medicine (BUSM) have concluded that the 940nm wavelength laser is superior for treating facial spider veins (telangiectasias) as compared to the 532nm wavelength laser. The findings, which appear in the recent issue of Lasers in Surgery and Medicine, are the first time these lasers were tested against each other for superiority.

7 Oct 2009

Phase 2 clinical study results of TOPICA's luliconazole for athlete's foot announced

TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.

6 Oct 2009

Pain News and Research

Latest Pain News and Research

BIOLASE Technology honored with the Deloitte Tech Evolution Award

Muscle Flex develops a strong portfolio of 'Water' related products to maintain healthy lifestyle

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

New Palliative Medicine Fellowship program for Pacific Northwest physicians

Biostar Pharmaceuticals' new drug application granted clearance for clinical trials

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Electrostimulation techniques for osteoarthritis still unclear

Transenterix raises $55 million to manufacture and market its revolutionary laparoscopic surgical platform

Free educational brochure on physical therapy

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

Opioid drugs may not be effective for osteoarthritis

Cochrane Systematic Review finds Abatacept effective against rheumatoid arthritis

New ultrasound probe effective for treating kidney stones

Research must focus on discovering potential causes and treatments for Bell's palsy

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Aerobic and strength training exercises safe and effective for rheumatoid arthritis patients

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

Phase 2 clinical study results of TOPICA's luliconazole for athlete's foot announced

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Pain News and Research

Latest Pain News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in